Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
A Randomized, Placebo-Controlled, Double-Blind Trial of Asenapine in the Prevention of Relapse After Long-Term Treatment of Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedThis study evaluated the safety and effectiveness of Metformin for people with schizophrenia.
This study has finished and is no longer accepting participants.
In Bhubaneswar
The Impact of Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex at Different Intensities and Frequencies on Cognition of Schizophrenic Patients
This study has finished and is no longer accepting participants.
In ArdabilThis study has finished and is no longer accepting participants.
In JerusalemAddition of Tiagabine to Second-Generation Antipsychotics in the Treatment of Recent-Onset Schizophrenia by Modification of Developmental Reorganization of the Prefrontal Cortex
This study is no longer accepting new participants.
In BostonThis study has finished and is no longer accepting participants.
In TübingenMechanisms of Improving Cognition and Negative Symptoms in Schizophrenia With N-Acetylcysteine: a Magnetic Resonance Spectroscopy Study of Glutamate and Glutathione
This study has finished and is no longer accepting participants.
In Los AngelesA Double Blind Sham Controlled Trial of tDCS for Treatment of Negative Symptoms in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In MontpellierThis study has finished and is no longer accepting participants.
In CatonsvilleResearchers compared Brexpiprazole (OPC-34712), Aripiprazole and placebo to find out how the approaches affected psychotic symptoms in young people with schizophrenia.
This study has finished and is no longer accepting participants.
In Oklahoma CityThis study evaluates the safety and effectiveness of GWP42003-P for people with schizophrenia.
This study ended early.
Multiple locations, including BentonvilleA Randomized, Double-Blind Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including BentonvilleWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.